Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Progress in immune checkpoint inhibitor therapies]Yoshiki AkatsukaInternational Journal of Hematology|June 18, 2026
Current status and challenges of TCR-T cell therapy for AML/MDSYoshiki Akatsuka[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2016
Historical perspectives and future directions of gene-modified T-cell therapyYoshiki AkatsukaFrontiers in Immunology|March 19, 2020
TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility AntigensYoshiki AkatsukaGan to Kagaku Ryoho. Cancer & Chemotherapy|May 20, 2008
[Antigen-specific allogeneic immunotherapy--selective augmentation of GVL effects]Yoshiki Akatsuka[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2023
[Hematological immune-related adverse events of immune checkpoint inhibitors and their management]Yoshiki AkatsukaInternational Journal of Hematology|March 10, 2004
The Fifth Nagoya International Blood And Marrow Transplantation Symposium: unlimited possibilities of hematopoietic cell transplantation: lessons from the past and prospects for the futureHikaru Nakajima, Yoshiki AkatsukaGMS Ophthalmology Cases|July 12, 2024
Bilateral reversible optic neuropathy as the first sign of Waldenström macroglobulinemaYoshiaki Shimada, Yoshiki Akatsuka, Kazuya NokuraImmunological Investigations|June 9, 2012
HLA-C matching status does not affect rituximab-mediated antibody-dependent cellular cytotoxicity by allogeneic natural killer CellsTakayuki Machino, Yasushi Okoshi, Yasuyuki Miyake, et al.Cancer Science|May 25, 2007
Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactionsYoshiki Akatsuka, Yasuo Morishima, Kiyotaka Kuzushima, et al.Pageof 9